Research and Development
New Alzheimer’s drug, lecanemab slows disease but divides opinions
November 30, 2022 Research and Development
Japanese drugmaker Eisai and its US partner Biogen have announced that their new drug to treat Alzheimer’s disease appeared to …
RadNet’s Aidence AI subsidiary and Google Health enter into agreement to bring lung cancer screening model to market
November 30, 2022 Research and Development
Aidence, an AI subsidiary of RadNet which looks at lung health, has partnered with Google Health to license Google Health’s …
University of Texas and Novartis Pharmaceuticals develop new computer platform for easier drug discovery
November 29, 2022 Research and Development
Researchers from both the University of Texas, US and Novartis Pharmaceuticals have developed a computer-based platform which appears to make …
Two-dose chemotherapy drug enters clinical trial for cancer patients
November 28, 2022 Research and Development
South Korean biotech firm Hyundai Bioscience’s innovative chemotherapy drug may be able to complete cancer treatments in two doses. The …
Lunit first SaMD in APAC region to secure CE mark and UKCA certification for AI-based radiology solution
November 23, 2022 Research and Development
Lunit, a South Korean medical software company, has become the first software as a medical device (SaMD) company in the …
BioInnovation Institute reveals new cohort entering Venture Lab programme
September 7, 2022 Research and Development
The group consists of nine ventures plus two corporate-sponsored innovation projects from Novo Nordisk – all aligned with BII’s focus …
New study reveals the range of co-morbidities faced by patients with type 2 diabetes
August 24, 2022 Research and Development
A new study has revealed the range and type of illnesses that people with type 2 diabetes are living with, …
Oxford Uni scientists study Siga’s Tpoxx for protection against monkeypox
August 24, 2022 Research and Development
The team at Oxford University, who conducted the landmark RECOVERY trial of COVID-19 therapies, is now studying if Siga Technologies’ …
Paediatric Investigation Plan approved by MHRA
August 24, 2022 Research and Development
Northwest Biotherapeutics has announced the approval from the MHRA of the company’s Paediatric Investigation Plan (PIP). The development, regulatory review, …
Togo becomes first country to eliminate four neglected tropical diseases
August 24, 2022 Research and Development
WHO has announced that the Republic of Togo has been confirmed as the first country to eliminate four devastating neglected …
Evonetix commences access programme for synthesised DNA
August 17, 2022 Research and Development
Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Evonetix has announced the opening …
Lynparza combination therapy gets FDA priority review for prostate cancer
August 17, 2022 Research and Development
Lynparza is being jointly developed by UK-based AstraZeneca and MSD AstraZeneca’s supplemental new drug application for Lynparza (olaparib) in combination …
Successful study to change the blood type of donor kidneys means access for more BAME recipients
August 17, 2022 Research and Development
Scientists at the University of Cambridge have successfully altered the blood type of donor kidneys in a study which could …
Patient with HNSCC dosed with triple combination therapy in Phase II of Genexine clinical trial
August 17, 2022 Research and Development
Genexine, a South Korean clinical-staged biopharmaceutical company, have announced the dosing with triple combination therapy of the first patient with …
Study highlights major factors in shaping cross-disorder cortical abnormalities
August 10, 2022 Research and Development
The study began by constructing maps of cortical abnormalities from thirteen neurodevelopmental, neurological, and psychiatric disorders. These maps came from …
Latest content
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
